2018 LYFEBULB-UNITEDHEALTH GROUP: INNOVATION CHALLENGE WINNER

Jon Margalit

CEO and Founder

About Jon Margalit

Jon Margalit, a startup entrepreneur, is one of millions who suffers from IBD. Jon set out to discover a convenient, nutritious solution made from real food that would both fill and settle his stomach. Jon is leveraging his expertise in business and sales, along with his success from prior startups to share his discovery with the world. Complete Start was founded in 2017 and is experiencing ongoing growth.

Prior to founding Complete Start, Jon launched and sold a multi-million dollar finance company, invented and patented a sport towel line, and revived a software company.

Finalists

LYFEBULB AND UNITEDHEALTH GROUP PRESENT EMPOWERING PATIENTS: AN INNOVATION CHALLENGE IN INFLAMMATORY BOWEL DISEASE

The 2018 Lyfebulb – UnitedHealth Group Innovation Challenge will recognize the top patient entrepreneurs developing innovative ideas for better management of Inflammatory Bowel Disease (IBD) using healthcare information technology, medical devices, consumer products or services. Patient entrepreneurs are individuals with a chronic disease, or who have a close relative or loved one with a chronic disease, who have founded or lead a company bringing innovative solutions to the market place.

24-25 JULY 2018 AT UNITEDHEALTH GROUP
9900 BREN RD E., MINNETONKA, MN 55343

Deadline for applications was June 7, 2018 at 11:59pm EDT

Thank you for your applications! Please keep an eye on this page for when we announce Patient Entrepreneur finalists and further Challenge updates.

Mission


The Innovation Challenge will bring together patient entrepreneurs with venture capitalists, key opinion leaders, patient advocates and leadership from UnitedHealth Group as well as Lyfebulb to promote awareness, discussions and connections around IBD and innovation in the care of patients with IBD. The attendees stimulate entrepreneurs’ efforts and ideas and provide professional discussion, direction, and inspiration.

 

Agenda

July 24, 2018 Morning
Arrival
July 24, 2018 Mid-Day
Participants and Team Introductory Lunch
July 24, 2018 Afternoon
Practice Pitches / Introductory Meetings
July 24, 2018 Evening
Networking Dinner
July 25, 2018 Early-Morning
Participants and Jury Breakfast
July 25, 2018 Morning
Live Pitch Session: Presentations
July 25, 2018 Mid-Day
Participants and Jury Lunch
July 25, 2018 Afternoon
Afternoon Workshops
July 25, 2018 Evening
Gala Dinner & Award Winner Announcement

The Pitch Competition

The 2018 Lyfebulb – UnitedHealth Group Innovation Challenge is the first of its kind for patient entrepreneurs in the area of Inflammatory Bowel Disease, following examples in diabetes and cancer.

Are you the patient entrepreneur who will win the 2018 Lyfebulb–UnitedHealth Group Innovation Award?


Some of the best patient entrepreneurs will pitch their innovative idea and business to venture capitalists, UnitedHealth Group and Lyfebulb leaders, key opinion leaders, as well as patient advocates and representatives. After their presentation, they will respond to a round of Q&A by the judging panel. Outstanding patient entrepreneurs will be awarded prize money to further develop their idea:

    • 1st Prize $25,000
    • 2nd Prize $15,000
    • 3rd Prize $10,000

Award & Judging Criteria

The award is open to patient entrepreneurs developing big ideas using healthcare information technology, medical devices, consumer products or services that disrupt and shape the future care and management of patients with IBD.

Eligibility

You are eligible to apply for the 2018 Lyfebulb-UnitedHealth Group Innovation Challenge if:

  • You work on innovative ideas and concepts for better care and management of IBD using healthcare information technology, medical devices, consumer products or services; and
  • You, or a family member or loved one, live with IBD; and
  • Your idea is something other than a pharmaceutical or diagnostic innovation.

WHAT ARE THE JUDGING CRITERIA?

The judging panel will look for evidence in the following categories:

  • Patient Entrepreneur story
  • Degree of innovation
  • Impact on patient needs
  • Feasibility of development and implementation into the marketplace

The Jury

Why do patient entrepreneurs matter?

Because they are personally motivated by their own disease, or that of a loved one, patient entrepreneurs have a unique ability to create value-adding disease management solutions beyond therapy. Our aim is to support user-driven innovation and provide a laser-focus on solutions for providing a higher quality of life for those living with IBD.

Together, We Are Stronger

Lyfebulb

Lyfebulb is a chronic disease-focused, patient empowerment platform that connects patients, Industry (manufacturers and payers) and investors to support user-driven innovation. Lyfebulb promotes a healthy, take-charge lifestyle for those affected by chronic disease. Grounded with its strong foundation in diabetes, the company has expanded disease states covered into cancer and IBD.

UnitedHealth Group

UnitedHealth Group (NYSE: UNH) is a diversified health and well-being company dedicated to helping people live healthier lives and helping make the health system work better for everyone. UnitedHealth Group offers a broad spectrum of products and services through two distinct platforms: UnitedHealth care, which provides health care coverage and benefits services; and Optum, which provides information and technology-enabled health services. For more information, visit UnitedHealth Group at www.unitedhealthgroup.com or follow @UnitedHealthGrp on Twitter.